Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease. - sprookjes - yvandenbroek - TriplyDB

Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.

Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.

http://www.wikidata.org/entity/Q33601926

about

Decorin binding proteins A and B in the serodiagnosis of Lyme disease in North America.Cross-Reactive Epitopes in Borrelia burgdorferi p66.Lyme Borreliosis Serology: Performance of Several Commonly Used Laboratory Diagnostic Tests and a Large Resource Panel of Well-Characterized Patient Samples.Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.Five-Antigen Fluorescent Bead-Based Assay for Diagnosis of Lyme Disease Structure-based Epitope Mapping of Mycobacterium tuberculosis Secretary Antigen MTC28 Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.Advances in Serodiagnostic Testing for Lyme Disease Are at Hand.A multiplex serologic platform for diagnosis of tick-borne diseases.

P2860

Q34701380-6883E3B5-2508-4DA8-A5F3-E3E1DC7A0561 Q35773909-D6DDED66-A3AF-4917-BD8D-6391253933DA Q36112203-254D9B51-F8C8-4B7B-9DA8-D6F3A63D3898 Q36297670-2022829F-CB0B-46AF-A896-E0819C0C301A Q36764399-6A6C3D72-EC59-423C-839D-3D559427BE84 Q40670691-758B74D9-AA2D-4713-A5DA-4F1E5059AAFF Q40996265-1B6704CC-9623-4E1A-94DD-B27CFCBE999E Q46836151-03975703-F9B0-4DEC-8348-8B30DA73534E Q49912320-49DB4E32-66B5-4FE0-94E1-960B5B1332F5

P2860

Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.

http://www.wikidata.org/entity/Q33601926

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.

@ast

Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.

@en

type

label

Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.

@ast

Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.

@en

prefLabel

Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.

@ast

Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.

@en

P1433

Q33601926-571922CC-3C7D-4299-88BA-30C8D6C70C43

P1476

Q33601926-835BBFCE-5CC4-4D9E-914B-123178854D51

P2093

Q33601926-AC795F3D-2AF3-4D19-B754-A273E374830E

P2860

Q33601926-073578D8-C0AC-4B6B-9296-DED097E8F19F

Q33601926-07E0810A-0654-4F0A-98C8-0BED3807250C

Q33601926-114889CF-25E8-41E7-B8F4-E4CDBC35B600

Q33601926-15FA0273-4C47-40EE-8AC9-56AE8239EB01

Q33601926-1D866131-BE4B-47E0-B317-E4528F75F0FC

Q33601926-23C6F7A8-166F-4CD0-AD38-D5388C6EBE46

Q33601926-2E3927B4-2CEE-43DB-9C25-096F4D601AAF

Q33601926-48630492-408F-4ABA-B97F-CC3D61408F75

Q33601926-4BD625B7-F291-4E85-BB7C-D805858CB49E

Q33601926-4D0E7C18-4286-424B-A3BC-A9BBC907B68B

P304

Q33601926-4AC92D4C-66AA-4DC1-B48D-1134D98189C7

P31

Q33601926-22AA331D-66F4-4808-AE07-EFAB7533F6AB

P356

Q33601926-67991726-26D8-4B1D-A653-5BEB050FF12B

P433

Q33601926-56A48023-B256-483C-B46A-2C9203C523B6

P478

Q33601926-1FD3CB36-4E88-4363-A152-F593558A679A

P50

Q33601926-0818AA28-90C0-4CAC-BDE8-4DD953651B5D

Q33601926-2199F0A6-8B5A-4E73-BBE7-F58E7B949A08

Q33601926-430B4D12-004E-42B5-AB6B-46F69CBDC71E

P577

Q33601926-BECE4770-E2AE-4B6C-AFA9-4D8E34D9A193

P5875

Q33601926-95B15B0F-E102-43E3-8839-579AA05E4CB8

P698

Q33601926-7151C7F3-E023-4F25-BC61-AA84AFD23079

P921

Q33601926-B613C34E-B1E2-43F2-B824-F42F598F39B2

P932

Q33601926-6C3D1F04-A988-4DD1-BA95-7D9B58FBE894

P356

P1433

Clinical and Vaccine Immunology

P1476

Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.

@en

P2093

Mary M Petzke

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis of lyme borreliosis.

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

Immunoblot interpretation criteria for serodiagnosis of early Lyme disease

Lyme borreliosis

Lyme disease-causing Borrelia species encode multiple lipoproteins homologous to peptide-binding proteins of ABC-type transporters

The borrelial fibronectin-binding protein RevA is an early antigen of human Lyme disease.

Peptide-based OspC enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis

Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.

BBK07 immunodominant peptides as serodiagnostic markers of Lyme disease.

P304

704-711

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00792-13

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Raymond J. Dattwyler

Giacomo Signorino

Paul M Arnaboldi

P577

2014-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260761336

http://www.w3.org/2001/XMLSchema#string

P698

24623628

http://www.w3.org/2001/XMLSchema#string

P921

P932

4018895

http://www.w3.org/2001/XMLSchema#string